Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Robert Donald Bruce Fraser 1924–2019

View through CrossRef
Robert Donald Bruce (Bruce) Fraser was a biophysicist who gained world-wide distinction for his extensive structural studies of fibrous proteins. Bruce began a part-time BSc degree at Birkbeck College, London, while working as a laboratory assistant. In 1942, aged 18, he interrupted his studies and volunteered for training as a pilot in the Royal Air Force (RAF). He was sent to the Union of South Africa and was selected for instructor training, specialising in teaching pilot navigation. At the end of the war he completed his BSc at King’s College, London, and followed this with a PhD. Bruce studied the structure of biological molecules, including DNA, using infra-red micro-spectroscopy in the Biophysics Unit at King’s led by physicist J. T. Randall FRS. During that time Bruce built a structure for DNA that was close to the Watson-Crick structure that gained them and Maurice Wilkins at Kings College, the Nobel Prize in 1962. In 1952, he immigrated to Australia with his family to a position in the newly formed Wool Textile Research Laboratories at the Commonwealth Scientific and Industrial Research Organisation (CSIRO). Here, Bruce established a biophysics group for research on the structure of wool and other fibrous proteins that flourished until his retirement. Over that period he was internationally recognized as the pre-eminent fibrous protein structuralist world-wide. Having been acting chief, Bruce was subsequently appointed chief of the Division of Protein Chemistry and he remained in that role until he took retirement in 1987.
Title: Robert Donald Bruce Fraser 1924–2019
Description:
Robert Donald Bruce (Bruce) Fraser was a biophysicist who gained world-wide distinction for his extensive structural studies of fibrous proteins.
Bruce began a part-time BSc degree at Birkbeck College, London, while working as a laboratory assistant.
In 1942, aged 18, he interrupted his studies and volunteered for training as a pilot in the Royal Air Force (RAF).
He was sent to the Union of South Africa and was selected for instructor training, specialising in teaching pilot navigation.
At the end of the war he completed his BSc at King’s College, London, and followed this with a PhD.
Bruce studied the structure of biological molecules, including DNA, using infra-red micro-spectroscopy in the Biophysics Unit at King’s led by physicist J.
T.
Randall FRS.
During that time Bruce built a structure for DNA that was close to the Watson-Crick structure that gained them and Maurice Wilkins at Kings College, the Nobel Prize in 1962.
In 1952, he immigrated to Australia with his family to a position in the newly formed Wool Textile Research Laboratories at the Commonwealth Scientific and Industrial Research Organisation (CSIRO).
Here, Bruce established a biophysics group for research on the structure of wool and other fibrous proteins that flourished until his retirement.
Over that period he was internationally recognized as the pre-eminent fibrous protein structuralist world-wide.
Having been acting chief, Bruce was subsequently appointed chief of the Division of Protein Chemistry and he remained in that role until he took retirement in 1987.

Related Results

If I Had Possession over Judgment Day: Augmenting Robert Johnson
If I Had Possession over Judgment Day: Augmenting Robert Johnson
augmentvb [ɔːgˈmɛnt]1. to make or become greater in number, amount, strength, etc.; increase2. Music: to increase (a major or perfect interval) by a semitone (Collins English Dicti...
John Bruce, Jr. : a Sixty-Nine Year Leadership Journey Throughout Change in the United States Army
John Bruce, Jr. : a Sixty-Nine Year Leadership Journey Throughout Change in the United States Army
Problem and Purpose The U.S. Army has changed radically in the 68 years since World War II ended, from uniforms to vehicles, from weaponry to organizational changes. While still t...
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within ...
Names of hydroids (Cnidaria, Hydrozoa) established by Charles McLean Fraser (1872–1946), excluding those from Allan Hancock Expeditions
Names of hydroids (Cnidaria, Hydrozoa) established by Charles McLean Fraser (1872–1946), excluding those from Allan Hancock Expeditions
An account is given of the names of families, genera, and species of hydroids established by C.M. Fraser of Canada, excluding those from Allan Hancock Pacific Expeditions and the A...
POSITIVE POLITENESS STRATEGIES USED BY DAVID MUIR AND DONALD TRUMP ON “ABC NEWS” AND IN “CHARLIE ROSE SHOW”
POSITIVE POLITENESS STRATEGIES USED BY DAVID MUIR AND DONALD TRUMP ON “ABC NEWS” AND IN “CHARLIE ROSE SHOW”
Abstract This research examines Donald Trump and David Muir’s Utterances on ABC News and in Charlie Rose Show. The researcher also focuses positive politeness used by David Muir an...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
DAMPAK TEKNOLOGI TERHADAP PROSES BELAJAR MENGAJAR
DAMPAK TEKNOLOGI TERHADAP PROSES BELAJAR MENGAJAR
DAFTAR PUSTAKAAditama, M. H. R., & Selfiardy, S. (2022). Kehidupan Mahasiswa Kuliah Sambil Bekerja di Masa Pandemi Covid-19. Kidspedia: Jurnal Pendidikan Anak Usia Dini, 3(...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...

Back to Top